TAVR Beyond Fetal Viability: An Alternative to Preterm Delivery in Symptomatic Severe Aortic Stenosis

Elizabeth Hoover, Tiffany Corlin, Jamie Lohr, Bethany Sabol, Yasuko Yamamura, Katherine Jacobs, S. Kimara March, Benjamin Gorbaty, Ganesh Raveendran

Research output: Contribution to journalArticlepeer-review

Abstract

A patient with structural valve degeneration of an aortic bioprosthesis with stenosis stage 3 underwent valve-in-valve transcatheter aortic valve replacement (TAVR) at 29 weeks with improvement. This is the first reported TAVR in the third trimester. TAVR may be an alternative to preterm delivery in cases of symptomatic aortic stenosis.

Original languageEnglish (US)
Article number102104
JournalJACC: Case Reports
Volume27
DOIs
StatePublished - Dec 6 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors

Keywords

  • aortic stenosis
  • bicuspid aortic valve
  • pregnancy
  • valve replacement

Fingerprint

Dive into the research topics of 'TAVR Beyond Fetal Viability: An Alternative to Preterm Delivery in Symptomatic Severe Aortic Stenosis'. Together they form a unique fingerprint.

Cite this